Eyenovia Adds $10 Million in HYPE to its Treasury Holdings in Preparation for Strategic Onchain Engagement
Eyenovia (NASDAQ: EYEN), a pioneer in ophthalmic technologies, has expanded its cryptocurrency holdings by purchasing an additional 265,872 HYPE tokens. This acquisition brings the company's total HYPE holdings to 1,306,452 tokens, acquired at an average price of $34.83 per token.
As the first publicly-listed U.S. company to build a strategic treasury of HYPE, the native token of the Hyperliquid protocol, Eyenovia plans to use these holdings to support ecosystem growth initiatives, including validator operations and protocol-level yield generation opportunities.
Eyenovia (NASDAQ: EYEN), pioniere nelle tecnologie oftalmiche, ha ampliato il suo portafoglio di criptovalute acquistando ulteriori 265.872 token HYPE. Questa acquisizione porta il totale dei token HYPE detenuti dall'azienda a 1.306.452 token, acquistati a un prezzo medio di 34,83 $ per token.
Essendo la prima società statunitense quotata in borsa a costituire una tesoreria strategica di HYPE, il token nativo del protocollo Hyperliquid, Eyenovia intende utilizzare questi asset per sostenere iniziative di crescita dell'ecosistema, inclusi operazioni di validazione e opportunità di generazione di rendimento a livello di protocollo.
Eyenovia (NASDAQ: EYEN), pionera en tecnologías oftálmicas, ha ampliado sus tenencias en criptomonedas al adquirir 265.872 tokens HYPE adicionales. Esta compra eleva el total de tokens HYPE de la compañía a 1.306.452 tokens, adquiridos a un precio promedio de $34.83 por token.
Como la primera empresa estadounidense que cotiza en bolsa en construir una tesorería estratégica de HYPE, el token nativo del protocolo Hyperliquid, Eyenovia planea utilizar estas tenencias para apoyar iniciativas de crecimiento del ecosistema, incluyendo operaciones de validación y oportunidades de generación de rendimiento a nivel de protocolo.
Eyenovia (NASDAQ: EYEN)는 안과 기술 분야의 선구자로서 추가로 265,872 HYPE 토큰을 매입하여 암호화폐 보유량을 확대했습니다. 이번 매입으로 회사의 총 HYPE 보유량은 1,306,452 토큰이 되었으며, 토큰당 평균 가격은 34.83달러입니다.
미국 상장사 중 최초로 Hyperliquid 프로토콜의 네이티브 토큰인 HYPE의 전략적 재무 자산을 구축한 Eyenovia는 이 보유 자산을 활용해 생태계 성장 이니셔티브를 지원하고, 검증자 운영 및 프로토콜 수준의 수익 창출 기회를 모색할 계획입니다.
Eyenovia (NASDAQ : EYEN), pionnier des technologies ophtalmiques, a augmenté ses avoirs en cryptomonnaies en achetant 265 872 tokens HYPE supplémentaires. Cette acquisition porte le total des tokens HYPE détenus par l'entreprise à 1 306 452 tokens, acquis à un prix moyen de 34,83 $ par token.
Première société américaine cotée en bourse à constituer une trésorerie stratégique en HYPE, le token natif du protocole Hyperliquid, Eyenovia prévoit d'utiliser ces avoirs pour soutenir les initiatives de croissance de l'écosystème, notamment les opérations de validateurs et les opportunités de génération de rendement au niveau du protocole.
Eyenovia (NASDAQ: EYEN), ein Vorreiter in der ophthalmologischen Technologie, hat seine Kryptowährungsbestände durch den Kauf von zusätzlichen 265.872 HYPE-Token erweitert. Dieser Erwerb bringt den Gesamtbestand des Unternehmens auf 1.306.452 Token, die zu einem durchschnittlichen Preis von 34,83 $ pro Token erworben wurden.
Als erstes börsennotiertes US-Unternehmen, das eine strategische Treasury von HYPE, dem nativen Token des Hyperliquid-Protokolls, aufbaut, plant Eyenovia, diese Bestände zur Unterstützung von Wachstumsinitiativen im Ökosystem zu nutzen, einschließlich Validator-Betrieb und Protokoll-basierten Ertragsmöglichkeiten.
- Expanded cryptocurrency holdings with 265,872 additional HYPE tokens
- Strategic positioning as first U.S. public company with HYPE treasury
- Potential for additional revenue through validator operations and yield generation
- Significant capital allocation to volatile cryptocurrency assets
- Exposure to cryptocurrency market risks and regulatory uncertainties
Increases total holdings to 1,306,452 HYPE
LAGUNA HILLS, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), a pioneer in ophthalmic technologies and the first publicly-listed U.S. company to build a strategic treasury of HYPE, the native token of the Hyperliquid protocol, today announced that it has acquired an additional 265,872 HYPE tokens, expanding its total holdings to 1,306,452 HYPE purchased at an average price of
“We continue to see strong signals from the market and prospective partners affirming the importance of HYPE's role in next-generation financial infrastructure,” said Hyunsu Jung, Chief Investment Officer of Eyenovia. “This latest token acquisition reflects our deepening commitment to the Hyperliquid network and our long-term conviction in its potential to redefine onchain finance.”
The additional holdings are expected to support the Company’s participation in ecosystem growth initiatives, including its own validator operations and upcoming opportunities to generate yield at the protocol level.
About the Hyperliquid Platform and the HYPE Token
Hyperliquid is a layer one blockchain (L1) optimized from the ground up for high frequency, transparent trading. The blockchain includes fully onchain perpetual futures and spot order books, with every order, cancel, trade, and liquidation occurring within 70 millisecond block times. It also hosts the HyperEVM, a general-purpose smart contract platform that, like Ethereum, supports permissionless decentralized financial applications.
HYPE is the native token of Hyperliquid. Staked HYPE in particular provides utility for users via reduced trading fees and increased referral bonuses. Circulating HYPE is autonomously purchased and sequestered by the blockchain itself with the trading fees generated on the network’s order books. As of June 2025, more than 25 million HYPE has been sequestered by this mechanism, and the token has become the 12th-largest cryptocurrency by market capitalization.
About Eyenovia, Inc.
Eyenovia, Inc. is a pioneering digital ophthalmic technology company and the first U.S. publicly listed company building a long-term strategic treasury of Hyperliquid’s native token, HYPE. With this dual focus, Eyenovia continues to aim to execute on its vision to revolutionize topical eye treatment while providing its shareholders with simplified access to the Hyperliquid ecosystem, one of the fastest growing, highest revenue-generating blockchains in the world. Eyenovia’s new strategy is designed to allow shareholders to benefit from a gradually compounding exposure to HYPE, both from its native staking yield and additional revenues generated from its unique on-chain utility.
Eyenovia is also developing its proprietary Optejet User Filled Device (UFD) that is designed to work with a variety of topical ophthalmic liquids, including artificial tears and lens rewetting products. The Optejet is especially useful in chronic front-of-the-eye diseases due to its ease of use, enhanced safety and tolerability, and potential for superior compliance versus standard eye drops. Together, these benefits may result in higher treatment compliance and better outcomes for patients and providers.
For more information, please visit Eyenovia.com.
Forward Looking Statements
Except for historical information, all the statements, expectations and assumptions contained in this press release are forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements, our future activities or other future events or conditions, including the estimated market opportunities for our platform technology, the viability of, and risks associated with, our cryptocurrency treasury strategy, the clinical trials that may be necessary in connection with the clearance of the Optejet UFD, and the timing for sales growth of our approved products. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and in some cases are likely to, differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors discussed from time to time in documents which we file with the U.S. Securities and Exchange Commission.
In addition, such statements could be affected by risks and uncertainties related to, among other things: risks of our clinical trials, including, but not limited to, the potential advantages of our products, and platform technology; the rate and degree of market acceptance and clinical utility of our products; our estimates regarding the potential market opportunity for our products; reliance on third parties to develop and commercialize our products; the ability of us and our partners to timely develop, implement and maintain manufacturing, commercialization and marketing capabilities and strategies for our products; intellectual property risks; changes in legal, regulatory, legislative and geopolitical environments in the markets in which we operate and the impact of these changes on our ability to obtain regulatory approval for our products and product candidates; our competitive position; our ability to raise additional funds to maintain our business operations and to make payments on our debt obligations as and when necessary; and the risks of our cryptocurrency strategy as detailed in our Current Report on Form 8-K filed on June 27, 2025.
Any forward-looking statements speak only as of the date on which they are made, and except as may be required under applicable securities laws, Eyenovia does not undertake any obligation to update any forward-looking statements.
| Eyenovia Investor Contact: Eric Ribner LifeSci Advisors, LLC eric@lifesciadvisors.com (646) 751-4363 |
FAQ
How many HYPE tokens does Eyenovia (EYEN) now hold in total?
What is the purpose of Eyenovia's HYPE token acquisition?
What is significant about Eyenovia's HYPE token holdings?
How much did Eyenovia (EYEN) pay for its HYPE tokens?
What are Eyenovia's plans for its HYPE token holdings?
